SCHEMBL30729917

SCHEMBL30729917

CC(C)(C)OC(=O)Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1F

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 20/20 0.70
▸ BRAF P15056 14/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15541508 1.00 KDR (0.70) KDRBRAF
SCHEMBL30729916 1.00 KDR (0.70) KDRBRAF
SCHEMBL27311398 0.96 KDR (0.66) KDRBRAF
SCHEMBL27305737 0.86 KDR (0.54) KDRBRAF
SCHEMBL18099204 0.86 KDR (0.69) KDRBRAF
SCHEMBL15559536 0.85 KDR (0.69) KDRBRAF
SCHEMBL16895204 0.84 KDR (0.64) KDRBRAF
SCHEMBL29834742 0.84 KDR (0.51) KDRBRAF
SCHEMBL16907661 0.83 KDR (1.00) KDRBRAF
SCHEMBL16895218 0.82 MAPK14 (0.53) KDRBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026056-A2 HETEROARYL COMPOUNDS AS EGFR INHIBITORS AND THEIR USES ACCUTAR BIOTECHNOLOGY, INC. (US) 2024-02-01 — — WO disclosed
Send feedback